We rely on the generosity and financial support from the community to advance scientific research so more RET-positive lung cancer patients can live fuller, healthier lives. We are committed to financial accountability and transparency, and we aim to be the best possible stewards of the generous financial contributions from our donors and partners.
Since our inception in 2021, we have awarded more than $1 million in RET-positive cancer research grants. We also educate patients and caregivers across the country about how participating in clinical trials and biomarker testing can improve RET-positive treatment options and patient survival.
